. . . . . . . . . . . . . . . . "Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study"@nl . . . . . . . . . . . . . . . . . "21279703" . . . . . "279-284" . . . . . . . . "Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study"@en . . . . . . . . . . . . . . . . . . "Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study"@nl . "Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study"@en . . . "scientific article published on 30 January 2011"@en . . . . "im Januar 2011 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . . . . . "29" . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en xineru de 2011"@ast . . . . . "Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study"@en . . . . . . . "10.1007/S12032-010-9811-X" . . "Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study"@en . "Hend Ahmed El-Hadaad" . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0441\u0456\u0447\u043D\u0456 2011"@uk . "1015959564" . "Ahmed Abo-Elyazeed" . . . . "Hanan Ahmed Wahba" . . "2011-01-30T00:00:00Z"^^ . . . . . . . . . . . . "wetenschappelijk artikel"@nl . . . . "1" . . . . . "Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study"@nl . .